Lisata Therapeutics, Inc.
LSTA
$2.50
-$0.03-1.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 70.00K | -- | 1.00M | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 70.00K | -- | 1.00M | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 70.00K | -- | 1.00M | -- | -- |
| SG&A Expenses | 2.69M | 3.25M | 3.00M | 2.79M | 2.92M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.94M | 5.85M | 5.95M | 5.34M | 5.52M |
| Operating Income | -4.87M | -5.85M | -4.95M | -5.34M | -5.52M |
| Income Before Tax | -4.66M | -5.69M | -4.61M | -4.93M | -5.04M |
| Income Tax Expenses | -- | -962.00K | 0.00 | -- | -- |
| Earnings from Continuing Operations | -4.66M | -4.72M | -4.61M | -4.93M | -5.04M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.66M | -4.72M | -4.61M | -4.93M | -5.04M |
| EBIT | -4.87M | -5.85M | -4.95M | -5.34M | -5.52M |
| EBITDA | -4.82M | -5.80M | -4.91M | -5.29M | -5.48M |
| EPS Basic | -0.54 | -0.55 | -0.55 | -0.59 | -0.61 |
| Normalized Basic EPS | -0.34 | -0.41 | -0.36 | -0.37 | -0.38 |
| EPS Diluted | -0.54 | -0.55 | -0.55 | -0.59 | -0.61 |
| Normalized Diluted EPS | -0.34 | -0.41 | -0.36 | -0.37 | -0.38 |
| Average Basic Shares Outstanding | 8.61M | 8.60M | 8.40M | 8.32M | 8.31M |
| Average Diluted Shares Outstanding | 8.61M | 8.60M | 8.40M | 8.32M | 8.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |